COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1394: Articles 13931-13940  | Next

Evaluation of the Access Bio CareStartTM rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts
Suliman, S., Matias, W. R., Fulcher, I. R., Molano, F. J., Collins, S., Uceta, E., Zhu, J., Paxton, R. M., Gonsalves, S. F., Harden, M. V., Fisher, M., Meldrim, J., Gabriel, S., Franke, M. F., Hung, D., Smole, S. C., Madoff, L. C., Ivers, L. C.
10.1101/2021.06.17.21259109 — Posted: 2021-06-20
Prevalence evolution of SARS-CoV-2 infection in the Municipality of Sao Paulo, 2020 - 2021
Albuquerque, J. O. M. d., Kamioka, G. A., Madalosso, G., Costa, S. A., Ferreira, P. B., Pino, F. A., Sato, A. P. S., Carvalho, A. C. A. d., Amorim, A. B. P., Aires, C. C., Kataoka, A. P. A. G., Savani, E. S. M. M., Bessa, T. A. F., Aguiar, B. S. d., Failla, M. A., Santos, E. A. d., Brito, E. M. T., Santos, M. C. H. d., Silva, S. M. S. e., Caldeira, L. A. V., Zamarco, L. C., Fonseca, S. M. S., Lima, M. M. d. C., Marques, I. A., Silva, F. E. V. d., Glasser, P. R., Burihan, P. C. P. R., Cavazzana, C. L., Lara, R. C., Mello, D. S. d., Pellini, A. C. G., Nishio, F. Y., Kian, F. M., Braga, E. d. S., Bertelli, N. M. P., Fracini, W., Goncalves, M. D. A., Zular, P. S., Piva, R. d. S., Masi, E. d.
10.1101/2021.06.16.21256530 — Posted: 2021-06-20
Mutations within the Open Reading Frame (ORF) including Ochre stop codon of the Surface Glycoprotein gene of SARS-CoV-2 virus erase potential seed location motifs of human non-coding microRNAs.
Goyani, K. H., Vaniawala, S., Mukhopadhyaya, P. N.
10.1101/2021.06.19.449095 — Posted: 2021-06-19
The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patients
Cerbulo-Vazquez, A., Garcia-Espinosa, M., Briones-Garduno, J. C., Arriaga-Pizano, L. A., Ferat-Osorio, E., Zavala-Barrios, B., Cabrera-Rivera, G. L., Miranda-Cruz, P., Garcia de la Rosa, M. T., Prieto-Chavez, J. L., Rivero-Arredondo, V., Madera-Sandoval, R. L., Cruz-Cruz, A., Salazar-Rios, E., Salazar-Rios, M. E., Serrano-Molina, D., De Lira-Barraza, R. C., Villanueva-Compean, A. H., Esquivel-Pineda, A., Ramirez-Montes de Oca, R., Caldino-Soto, F., Ramirez-Garcia, L. A., Flores-Padilla, M. G., Moreno-Alvarez, O., Guerrero-Avendano, G. M. L., Lopez-Macias, C.
10.1101/2021.06.18.449054 — Posted: 2021-06-19
Differences in IgG antibody responses following BNT162b2 and mRNA-1273 Vaccines
Montoya, J. G., Adams, A. E., Bonetti, V., Deng, S., Link, N. A., Pertsch, S., Olson, K., Li, M., Dillon, E. C., Frosch, D. L.
10.1101/2021.06.18.449086 — Posted: 2021-06-19
Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with Pol α - Primase
Kilkenny, M. L., Veale, C. E., Guppy, A., Hardwick, S. W., Chirgadze, D. Y., Rzechorzek, N. J., Maman, J. D., Pellegrini, L.
10.1101/2021.06.17.448816 — Posted: 2021-06-19
Discovery of SARS-CoV-2 Mpro Peptide Inhibitors from Modelling Substrate and Ligand Binding
Chan, H. T. H., Moesser, M. A., Walters, R. K., Malla, T. R., Twidale, R. M., John, T., Deeks, H. M., Johnston-Wood, T., Mikhailov, V., Sessions, R. B., Dawson, W., Salah, E., Lukacik, P., Strain-Damerell, C., Owen, D., Nakajima, T., Swiderek, K., Lodola, A., Moliner, V., Glowacki, D. R., Walsh, M. A., Schofield, C. J., Genovese, L., Shoemark, D., Mulholland, A. J., Duarte, F., Morris, G. M.
10.1101/2021.06.18.446355 — Posted: 2021-06-19
Mapping the host protein interactome of non-coding regions in SARS-CoV-2 genome
Jiang, L., Xiao, M., Liao, Q.-Q., Zheng, L., Li, C., Liu, Y., Yang, B., Ren, A., Jiang, C., Feng, X.-H.
10.1101/2021.06.19.449092 — Posted: 2021-06-19
Sequencing using a two-steps strategy reveals high genetic diversity in the S gene of SARS-CoV-2 after a high transmission period in Tunis, Tunisia.
Fares, W., Ghedira, K., Gdoura, M., Chouikha, A., Haddad-Boubaker, S., Khediri, M., Ayouni, K., Lamari, A., Touzi, H., Hammemi, W., Medeb, Z., Sadraoui, A., Hogga, N., Ben Aleya, N., Triki, H.
10.1101/2021.06.18.449083 — Posted: 2021-06-19
SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Strain-specific Neutralizing Antibodies in Naïve and Previously Infected Recipients
Narowski, T. M., Raphel, K., Adams, L. E., Huang, J., Vielot, N. A., Jadi, R., de Silva, A. M., Baric, R. S., Lafleur, J. E., Premkumar, L.
10.1101/2021.06.19.449100 — Posted: 2021-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).